Thromboembolic Events Among Patients with Hepatitis C Virus Infection and Cirrhosis: A Matched-Cohort Study
Authors:
- 22 July 2014
- journal article
- Published by Springer Nature in Advances in Therapy
- Vol. 31 (8) , 891-903
Abstract
Portal vein thrombosis is a known risk among patients with cirrhosis, but the incidence of other thromboembolic events among patients with liver disease is inadequately delineated. This study examined the incidence of venous and arterial thromboembolic events in patients with cirrhosis and hepatitis C virus (HCV) infection and matched comparators. Patients diagnosed with HCV or cirrhosis of various etiologies were identified from a large medical claims database and matched by age and sex to comparator cohorts. New-onset diagnoses of venous and arterial thromboembolic events were determined. The incidence rate of each event was calculated and rate ratios computed using Poisson regression models, adjusting for baseline factors. The study included 22,733 HCV-infected patients and 68,198 comparators, and 15,158 cirrhosis patients and 45,473 comparators. The incidence of any thromboembolic event was 233.4 events per 10,000 person-years for the HCV cohort and 138.5 per 10,000 person-years for the comparators; the adjusted incidence rate ratio for any thromboembolic event was 1.62 (95% confidence interval [CI]: 1.48–1.77). For the cirrhosis patients and comparators, the crude rates of any thromboembolic event were 561.1 and 249.7 per 10,000 person-years, respectively. The adjusted incidence rate ratio was 2.28 (95% CI: 2.11–2.47). Arterial events, especially unstable angina and transient ischemic attack, were the most frequent events seen in both the HCV and cirrhosis cohorts, but venous events, especially portal vein thrombosis, showed a more pronounced elevation in patients with liver disease. Patients with HCV and cirrhosis of various etiologies are at increased risk of several types of thromboembolic events. Physicians should consider this increased risk when managing patients with liver disease.Keywords
This publication has 27 references indexed in Scilit:
- Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population‐based cohort study*Journal of Viral Hepatitis, 2011
- Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition?Hepatology International, 2010
- Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy?HPB, 2009
- Chronic kidney disease and venous thromboembolism: epidemiology and mechanismsCurrent Opinion in Pulmonary Medicine, 2009
- Stroke Incidence and Mortality Rates 1987 to 2006 Related to Secular Trends of Cardiovascular Risk Factors in Gothenburg, SwedenStroke, 2009
- Hepatitis C Virus Infection and the Risk of Coronary DiseaseClinical Infectious Diseases, 2009
- Long-Term Trends in Myocardial Infarction Incidence and Case Fatality in the National Heart, Lung, and Blood Institute’s Framingham Heart StudyCirculation, 2009
- Deep Vein Thrombosis and Pulmonary Embolism in Cirrhosis PatientsDigestive Diseases and Sciences, 2008
- No Association between Hepatitis C Virus Seropositivity and Acute Myocardial InfarctionClinical Infectious Diseases, 2006
- Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosisJournal of Hepatology, 2004